A detailed history of Ifm Investors Pty LTD transactions in Danaher Corp stock. As of the latest transaction made, Ifm Investors Pty LTD holds 147,142 shares of DHR stock, worth $34.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
147,142
Previous 150,569 2.28%
Holding current value
$34.6 Million
Previous $37.6 Million 8.73%
% of portfolio
0.4%
Previous 0.38%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$239.25 - $280.76 $819,909 - $962,164
-3,427 Reduced 2.28%
147,142 $40.9 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $442,523 - $503,534
1,879 Added 1.26%
150,569 $37.6 Million
Q1 2024

Apr 22, 2024

SELL
$224.58 - $256.19 $239,402 - $273,098
-1,066 Reduced 0.71%
148,690 $37.1 Million
Q4 2023

Jan 12, 2024

BUY
$185.1 - $233.13 $1 Million - $1.26 Million
5,413 Added 3.75%
149,756 $34.6 Million
Q3 2023

Oct 26, 2023

BUY
$233.08 - $265.59 $1.2 Million - $1.36 Million
5,128 Added 3.68%
144,343 $35.8 Million
Q2 2023

Jul 27, 2023

BUY
$224.99 - $256.14 $1.33 Million - $1.51 Million
5,892 Added 4.42%
139,215 $33.4 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $952,287 - $1.1 Million
3,972 Added 3.07%
133,323 $33.6 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $2 Million - $2.33 Million
8,271 Added 6.83%
129,351 $34.3 Million
Q3 2022

Oct 12, 2022

BUY
$247.06 - $1507.4 $2.2 Million - $13.4 Million
8,918 Added 7.95%
121,080 $31.3 Million
Q2 2022

Jul 15, 2022

BUY
$237.11 - $299.66 $2.85 Million - $3.6 Million
12,013 Added 12.0%
112,162 $28.4 Million
Q1 2022

Apr 13, 2022

BUY
$257.27 - $315.76 $4.36 Million - $5.35 Million
16,955 Added 20.38%
100,149 $29.4 Million
Q4 2021

Jan 18, 2022

SELL
$292.08 - $329.01 $307,560 - $346,447
-1,053 Reduced 1.25%
83,194 $27.4 Million
Q3 2021

Oct 13, 2021

BUY
$272.21 - $332.43 $36,476 - $44,545
134 Added 0.16%
84,247 $25.6 Million
Q2 2021

Jul 16, 2021

BUY
$225.08 - $271.69 $3.47 Million - $4.19 Million
15,415 Added 22.44%
84,113 $22.6 Million
Q1 2021

May 05, 2021

BUY
$212.38 - $245.9 $1.53 Million - $1.77 Million
7,192 Added 11.69%
68,698 $15.5 Million
Q4 2020

Jan 13, 2021

BUY
$212.5 - $245.46 $1.75 Million - $2.03 Million
8,250 Added 15.49%
61,506 $13.7 Million
Q3 2020

Oct 16, 2020

BUY
$177.16 - $215.33 $1.22 Million - $1.48 Million
6,869 Added 14.81%
53,256 $11.5 Million
Q2 2020

Jul 13, 2020

SELL
$128.7 - $176.83 $2.22 Million - $3.05 Million
-17,228 Reduced 27.08%
46,387 $8.2 Million
Q1 2020

Apr 09, 2020

SELL
$121.39 - $169.05 $284,173 - $395,746
-2,341 Reduced 3.55%
63,615 $8.96 Million
Q4 2019

Jan 13, 2020

SELL
$133.47 - $153.48 $439,917 - $505,870
-3,296 Reduced 4.76%
65,956 $10.1 Million
Q3 2019

Nov 01, 2019

BUY
$135.4 - $146.47 $3.38 Million - $3.66 Million
24,971 Added 56.39%
69,252 $10 Million
Q2 2019

Jul 16, 2019

BUY
$124.88 - $143.73 $463,429 - $533,382
3,711 Added 9.15%
44,281 $6.33 Million
Q1 2019

Apr 18, 2019

BUY
$97.62 - $132.29 $418,008 - $566,465
4,282 Added 11.8%
40,570 $5.36 Million
Q4 2018

Jan 23, 2019

BUY
$94.85 - $109.54 $306,650 - $354,142
3,233 Added 9.78%
36,288 $3.74 Million
Q3 2018

Oct 22, 2018

BUY
$98.13 - $108.9 $474,851 - $526,967
4,839 Added 17.15%
33,055 $3.59 Million
Q2 2018

Jul 09, 2018

BUY
$96.1 - $103.24 $839,914 - $902,317
8,740 Added 44.88%
28,216 $2.78 Million
Q1 2018

May 11, 2018

BUY
$92.16 - $103.8 $180,264 - $203,032
1,956 Added 11.16%
19,476 $1.91 Million
Q4 2017

Jan 29, 2018

BUY
$85.26 - $94.62 $5,371 - $5,961
63 Added 0.36%
17,520 $1.63 Million
Q3 2017

Nov 16, 2017

BUY
$79.29 - $88.45 $30,130 - $33,611
380 Added 2.23%
17,457 $1.5 Million
Q2 2017

Aug 10, 2017

BUY
N/A
4,456 Added 35.31%
17,077 $1.44 Million
Q1 2017

Aug 17, 2017

BUY
N/A
12,621
12,621 $1.08 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.